Surgical Treatment of Ischemic Mitral Regurgitation (TIME)
The Effect of Different Surgical Methods in the Treatment of Patients With Ischemic Mitral Regurgitation and Assess the Dynamics of Heart Failure and the Effectiveness of Surgical Treatment of Mitral Valve.
Sponsor: Meshalkin Research Institute of Pathology of Circulation
Listed as NCT01368575, this PHASE4 trial focuses on Mitral Valve Insufficiency and remains ongoing. Sponsored by Meshalkin Research Institute of Pathology of Circulation, it has been updated 7 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
▶ Show 2 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jan 2017 — Oct 2017 [monthly]
Recruiting PHASE4
First recorded
May 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Meshalkin Research Institute of Pathology of Circulation
For direct contact, visit the study record on ClinicalTrials.gov .